BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, December 29, 2025
Home
»
Newsletters
» BioWorld MedTech
BioWorld MedTech
March 7, 2019
View Archived Issues
Patients tell their stories as Congress continues to shine light on pricing
Read More
Next G20 meeting to focus on funding mechanisms for global health care R&D
Read More
A Bug's Life 2: Seventure closing in on second microbiome fund
Read More
Beetles sing money tune as Verrica result punches cantharidin ticket to ride
Read More
Appointments and advancements
Read More
Financings
Read More
Daily M&A
Read More
Regulatory front
Read More
Product briefs
Read More
Other news to note
Read More
BioWorld MedTech's Orthopedics Extra
Read More
Neuronetics shines in fourth quarter, with Neurostar seeing a revenue bump
Neuronetics Inc. reported solid results for its fourth quarter, seeing revenue for its Neurostar Advanced Therapy come in at $4.8 million. That represented an increase of 37 percent vs. the prior year's figure of $3.5 million.
Read More
Panel gives Optune positive scores for Medicare outcomes
Read More
